热门资讯> 正文
Nektar Therapeutics启动拟议公开募股
2025-07-01 04:10
- 内克塔治疗(NKTR) 0
- 纳比特(NA) 0
- 盛大科技(SDA) 0
- Nektar Therapeutics (NASDAQ:NKTR) has commenced an underwritten public offering of shares of its common stock and pre-funded warrants to purchase shares of its common stock.
- NKTR -2.45% after hours to $25.11.
- Source: Press Release
More on Nektar Therapeutics
- Nektar Therapeutics Scores Big Phase 2b Win With REZPEG
- Nektar Therapeutics: 2 Data Readouts For REZPEG 2025 Could Establish Further POC
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
